Related Experiment Video

Updated: May 20, 2026

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
07:53

Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma

Published on: April 15, 2022

Elevated desmoglein-2 expression in multiple myeloma is a prognostic marker across genomic subtypes with impact on

Barbara J McClure1, John Toubia1,2, Charlotte E J Toomes3

  • 1Centre for Cancer Biology, College of Health, Adelaide University and SA Pathology, Adelaide, South Australia, Australia.

British Journal of Haematology
|May 18, 2026
PubMed
Abstract

No abstract available in PubMed .

Keywords:
desmoglein‐2multiple myelomaprognostic biomarker

More Related Videos

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker07:47

Multiomics Analysis of TMEM200A as a Pan-Cancer Biomarker

Published on: September 15, 2023

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...